MedTrace Logo

Provider Perceptions of Neuromuscular Blockade in ARDS

NCT03179709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2020-01-07

No results posted yet for this study

Summary

The proposed study will use qualitative methodology to understand health care provider perceptions of neuromuscular blockade (NMB) in patients with Acute Respiratory Distress Syndrome (ARDS). To achieve this goal the investigators will conduct a prospective ancillary study at four clinical centers participating in the NHLBI PETAL network as part of the ROSE (Reevaluation of Systemic Early Neuromuscular Blockade) clinical trial (NCT02509078). Using thematic content analysis of semistructured interviews with health care providers caring for patients enrolled in the ROSE trial the investigators will determine the barriers to NMB use and develop a framework for future NMB adoption in ARDS.

Conditions

  • Neuromuscular Blockade
  • Acute Respiratory Distress Syndrome

Interventions

BEHAVIORAL

Interview

The investigators will perform and analyze semi-structured interviews with enrolled participants.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Jeremy M Kahn, MD, MS · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-03-18
Completion
2018-03-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179709 on ClinicalTrials.gov